Material and Method: In a cross-sectional study, 50 patients with biopsy-proven primary focal segmental glomerolusclerosis were recruited. The proportion of globally and segmentally sclerosed glomeruli was determined during the first histopathological examination of renal biopsy specimens. Correlations of these variables with on admission serum level of creatinine and its clearance rate were investigated.
Results: Twenty-four males and 26 females with a mean age of 39.82±16.45 (range: 16-85) years were enrolled in the study. In a significant fashion, the proportions of segmental and global glomerulosclerosis were directly correlated with the serum level of creatinine and inversely with its clearance rate (r=-0.43 with p=0.002 and r=-0.45 with p=0.001, respectively).
Conclusion: Apart from the degree of interstitial fibrosis, the serum level of creatinine and its clearance rate are well correlated with the proportions of both segmentally and globally sclerosed glomeruli in primary focal segmental glomerulosclerosis.
A comprehensive evaluation, including a thorough historytaking and physical examination, as well as a complete laboratory evaluation such as urinalysis, 24-h urinary protein excretion, creatinine clearance (CCr), serum and urinary levels of creatinine, cholesterol, albumin, fasting blood glucose, and other tests to exclude systemic diseases as appropriate, were performed at the time of initial evaluation. CCr was calculated from the creatinine concentration in the collected urine sample (UCr), urine flow rate (V), and the plasma concentration (PCr) by this formula[4]:
Ccr=(Ucr*V)/Pcr
Potential confounding causes of creatinine rise were ruled out by a skilled nephrologist before histopathologic assessments. Renal specimens were obtained in all patients by percutaneous biopsy, and sections containing at least eight glomeruli were examined by a single skilled nephropathologist. Repeat biopsies following the diagnosis of FSGS were not included. The nephropathologist was blinded to the clinical and laboratory details of the patients.
The specimens were stained by Masson trichrome, Congo red, Periodic acid-Schiff (PAS) and Hematoxylin&Eosin and examined by light microscopy and immunofluorescence (Olympus™, PA, USA). The immunofluorescence findings were as follows: positive IgM and C3, as well as negative IgG, IgG, C4, C1q and fibrin/fibrinogen. On histopathologic assessment the interstitium showed mild to moderate patchy mononuclear inflammatory cell infiltration and fibrosis was mild and patchy. Tubular atrophy was about 30% up to 55% especially around affected glomeruli. Arterioles showed subintimal hyalinization and arteries show medial hypertrophy.
FSGS was defined based on the following criteria: (i) a lesion involving only some of the glomeruli in the biopsy with others remaining uninvolved, (ii) the involved glomeruli having a segmental sclerotic lesion with or without discrete capsular adhesions, and (iii) no clinical or pathological evidence for underlying primary disease that might produce secondary sclerosis.
Along with the first histopathological diagnosis of FSGS, segmentally and globally sclerosed glomeruli were counted separately in each field. At the same time, total glomerular count was also determined and then the proportion of segmentally and globally sclerosed glomeruli was calculated. The sclerotic score was determined based on following classification[6]:
I: Involvement <25% of total glomeruli
II: Involvement of 26%-75% of total glomeruli
III: Involvement >76% of total glomeruli
To assess errors of measurement, total glomeruli, as well as the segmentally and globally sclerosed glomeruli were recounted in 10 specimens selected randomly on 2 consecutive days by the same observer. Data from the two sets of measurements were compared. The limits of agreements were acceptable (i.e. within the 5% of the mean value).
Correlations of the number and proportion of segmentally or globally sclerosed glomeruli with serum level of creatinine and its clearance rate were examined. Other investigated variables in the current study were the patients’ age, gender and weight.
Statistical analysis
Statistical evaluation was made using SPSS for Windows V
18.0 (SPSS Inc., Il, USA). The independent samples T-test,
Mann-Whitney U-test, Chi-square test or Fisher’s exact
test were employed for comparison where appropriate.
Correlation between different variables was examined by
calculating the Spearman’s rho coefficient. P values less
than 0.05 were regarded as significant.
Table II: Correlations between the proportion of sclerosed glomeruli and other variables
Figure 1: The scatter diagram of segmentally sclerosed glomeruli versus serum creatinine.
Figure 2: The scatter diagram of segmentally sclerosed glomeruli versus creatinine clearance.
Figure 3: The scatter diagram of globally sclerosed glomeruli versus serum creatinine.
Figure 4: The scatter diagram of globally sclerosed glomeruli versus creatinine clearance.
1) Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004, 15:2169-2177 [ Özet ]
2) Crook ED, Habeeb D, Gowdy O, Nimmagadda S, Salem M: Effects of steroids in focal segmental glomerulosclerosis in a predominantly African-American population. Am J Med Sci 2005, 330:19-24 [ Özet ]
3) D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 1994, 46:1223-1241 [ Özet ]
4) Brenner BM: Brenner and Rector's The Kidney. 6th ed., USA, Saunders, 2000.
5) Korbet SM: Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002, 62:2301-2310 [ Özet ]
6) Jennette JC, Olson JL, Schwartz MM, Silva FG: Heptinstall's Pathology of the Kidney. 6th ed., USA, Lippincott Williams & , 2006.
7) Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 1996, 50:1734-1746 [ Özet ]
8) Atangwho IJ, Ebong PE, Eteng MU, Eyong EU, Obi AU: Effect of Vernonia amygdalina Del Leaf on Kidney Function of Diabetic Rats. Int J Pharmacol 2007, 3: 143-148 DOI: 10.3923/ijp.2007.143.148
9) Abdin AA, Draz EI, Sarhan NI: Evaluation of the Chemoprotective Role of N-Acetylcysteine on Cisplatin-Induced Nephrotoxicity: New Aspect of an Old Drug. Int J Pharmacol 2008, 4: 339-351 DOI: 10.3923/ijp.2008.339.351
10) Taheri D, Chehrei A, Samanianpour P, Hassanzadeh A, Sadrarhami S, Seyrafian S: Correlation of kidney biopsy findings and clinical manifestations of primary focal and segmental glomerulosclerosis. Saudi J Kidney Dis Transpl 2009, 20:417-423 [ Özet ]
11) Lee HS, Spargo BH: Significance of renal hyaline arteriolosclerosis in focal segmental glomerulosclerosis. Nephron 1985, 41:86-93 [ Özet ]
12) Chiang ML, Hawkins EP, Berry PL, Barrish J, Hill LL: Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study. Clin Nephrol 1988, 30:8-14 [ Özet ]
13) Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R: Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am J Kidney Dis 1995, 25:845-852 [ Özet ]
14) Lee HS, Kim TS: A morphometric study of preeclamptic nephropathy with focal segmental glomerulosclerosis. Clin Nephrol 1995, 44:14-21 [ Özet ]
15) Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995, 25:534-542 [ Özet ]
16) Danilewicz M, Wagrowska-Danilewicz M: Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study. Pol J Pathol 1996, 47:209-214 [ Özet ]